FluoSphera has developed human multi-tissue systems that accurately replicate and analyze how a drug interacts with multiple organs. FluoSphera’s technology addresses a critical gap in preclinical drug development by enabling the selection of the best candidate drugs based on their predicted systemic response in humans — ultimately determining clinical success for patients. To know more
